Our findings suggest that elevated expression of RAB10 in BC suggests a poor prognosis for BC, and that its ability to promote BC cell proliferation, migration and invasion in vitro is associated with tumor immune infiltrating cells in BC and is a potential biomarker or molecular target for BC. This evidence concerns the gene RAB10 and breast cancer.